Fully Automated Coagulometer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Fully Automated Coagulometer Market is segmented by Product Type (Coagulator Instrument, Consumables, Accessories), End User, and Geography.

Market Snapshot

Fully Automated Coagulometer Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.2 %
Fully Automated Coagulometer Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The fully automated coagulometer is expected to register rapid growth over the forecast period due to the increasing prevalence of blood-related disorders and developing products.

  •  Hemophilia is a type of blood disorder which is inherited, it prevents the blood from clotting. According to the World Federation of Haemophilia data, in 2018, around 210,454 people worldwide were diagnosed with hemophilia.
  •  Moreover, von willebrand disease prevalent cases were accounted to be approximately 78,547 and other bleed disorders were around 48,640. This is expected to boost the demand for fully automated coagulometer. However, the high cost of instruments is expected to obstruct the market growth.

Scope of the Report

Coagulometer is a device used for analyzing the hemostasis mechanism. It detects blood clots in blood and blood vessels thus helps in identifying diseases related to blood and cardiovascular. The market is segmented by product type, end user, and geography.

By Product Type
Coagulation System
By End User
Diagnostic Laboratories
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Hospital Segment is Expected to Hold a Major Market Share in the Fully Automated Market

  • The increasing number of hospitals and it’s developing infrastructure is increasing the demand for fully automated coagulometer devices. According to the American Hospital Association, there are around 5,198 community hospitals in the United States. Furthermore, according to Centers for Medicare & Medicaid Services, the government of United States spent around 4.6% more in 2018 than the preceding year for improving the healthcare infrastructure.
  • Also, the increasing adoption of point of care testing by hospitals due to its rapid diagnosis and results, is expected to fuel the demand of fully automated coagulometer.
Fully Automated Coagulometer Market Share

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the market due to the increasing burden of diseases related to blood and cardiovascular. According to the data published by the World Federation of Haemophilia in 2018, around 36,262 people were found to be suffering from some of the other blood disorders in the United States. Furthermore, according to the Center for Disease Control and Prevention, in 2017, around 18.2 million people aged 20 & above suffered from coronary artery disease. Hence, this factor is expected to drive the fully automated coagulometer market growth.

Fully Automated Coagulometer Market Growth

Competitive Landscape

Product launches and strategic alliances by companies are expected to drive the fully automated analyzer market growth. In 2017, Instrument Laboratory acquired Accriva Diagnostics for extending its product line into point of care diagnostics of coagulation and anti-platelet therapy. Furthermore, in 2018, Horiba introduced fully automated coagulometers, Yumizen G800 for laboratories, and Yumizen G1550 for clinical laboratories with a high workload. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are HemoSonics LLC, Siemens Healthcare, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Erba Group, Sysmex, Instrumentation Laboratory, Horiba, Haemonetics Corporation, and Grifols SA.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Blood Related Diseases

      2. 4.2.2 Emerging Trends in Product

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Test

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Coagulation System

      2. 5.1.2 Consumables

      3. 5.1.3 Accessories

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Diagnostic Laboratories

      3. 5.2.3 Other End Users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Erba Group

      3. 6.1.3 F. Hoffmann-La Roche Ltd

      4. 6.1.4 Grifols SA

      5. 6.1.5 HemoSonics LLC

      6. 6.1.6 Haemonetics Corporation

      7. 6.1.7 Horiba

      8. 6.1.8 Instrumentation Laboratory

      9. 6.1.9 Siemens Healthcare

      10. 6.1.10 Sysmex

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Fully Automated Coagulometer Market market is studied from 2018 - 2026.

The Fully Automated Coagulometer Market is growing at a CAGR of 8.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

HemoSonics LLC , Siemens Healthcare , Instrumentation Laboratory, Abbott Laboratories, F. Hoffmann-La Roche Ltd. are the major companies operating in Fully Automated Coagulometer Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!